|
FY2026
12 months to Jan 31, 2026
|
|
|---|---|
| Revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses | |
| Research and development | |
| Sales and marketing | |
| General and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Interest expense | |
| Other income (expense), net | |
| Loss on extinguishment of debt | |
| Gain (loss) on fair value adjustments | |
| Loss before income tax expense | |
| Income tax expense | |
| Net loss | |
| Net loss per share attributable to common stockholders: | |
| Basic net loss per share (in dollars per share) | |
| Diluted net loss per share (in dollars per share) | |
| Weighted-average shares outstanding used to compute net loss per share attributable to common stockholders, basic (in shares) | |
| Weighted-average shares outstanding used to compute net loss per share attributable to common stockholders, diluted (in shares) |
Loading...
